Chrome Extension
WeChat Mini Program
Use on ChatGLM

CD20-TCB, a Novel T-Cell-Engaging Bispecific Antibody, Can Be Safely Combined with the Anti-PD-L1 Antibody Atezolizumab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Blood(2019)

Cited 17|Views45
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined